Research ArticleCANCER

Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells

See allHide authors and affiliations

Science Advances  08 May 2019:
Vol. 5, no. 5, eaau5240
DOI: 10.1126/sciadv.aau5240
PDF Container

Stay Connected to Science Advances

Navigate This Article